Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Kaken Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	156,586	176,794	130,992	138,463	147,114	166,112
Market Cap Growth	-2.42%	34.97%	-5.40%	-5.88%	-11.44%	-15.14%
Enterprise Value	103,332	100,891	68,690	72,334	84,580	101,291
Last Close Price	4135.00	4370.72	3223.47	3301.76	3340.15	3595.09
PE Ratio	242.66	12.68	16.32	25.45	15.41	12.39
Forward PE	59.85	22.01	19.39	13.57	13.10	13.02
PS Ratio	1.91	1.88	1.82	1.90	1.94	2.22
PB Ratio	1.06	1.16	0.91	1.01	1.06	1.22
P/TBV Ratio	1.21	1.33	0.96	1.07	1.14	1.23
P/FCF Ratio	-	6.90	182.95	19.06	14.21	13.39
P/OCF Ratio	-	5.94	50.83	14.96	11.03	11.55
EV/Sales Ratio	1.26	1.07	0.95	0.99	1.11	1.35
EV/EBITDA Ratio	23.60	4.28	5.60	6.85	4.33	5.04
EV/EBIT Ratio	62.29	4.80	7.22	9.04	4.96	5.69
EV/FCF Ratio	-19.66	3.94	95.94	9.96	8.17	8.16
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	0.88	0.16	0.31	0.36	0.20	0.19
Debt / FCF Ratio	-	0.15	5.38	0.53	0.37	0.31
Asset Turnover	0.45	0.52	0.43	0.44	0.46	0.47
Inventory Turnover	2.06	1.96	2.05	2.19	2.28	2.48
Quick Ratio	3.52	3.01	4.68	4.49	4.98	4.60
Current Ratio	4.40	3.67	5.62	5.27	5.81	5.34
Return on Equity (ROE)	0.43%	9.41%	5.72%	3.95%	6.96%	10.13%
Return on Assets (ROA)	0.57%	7.26%	3.52%	3.02%	6.49%	6.92%
Return on Invested Capital (ROIC)	0.67%	8.65%	4.13%	3.54%	7.56%	8.16%
Return on Capital Employed (ROCE)	1.10%	13.10%	6.20%	5.50%	11.70%	12.50%
Earnings Yield	0.42%	7.89%	6.13%	3.93%	6.49%	8.07%
FCF Yield	-3.36%	14.50%	0.55%	5.25%	7.03%	7.47%
Dividend Yield	4.58%	3.43%	4.65%	4.54%	4.49%	4.17%
Payout Ratio	1112.14%	51.62%	70.49%	103.84%	59.84%	43.35%
Buyback Yield / Dilution	-0.88%	-1.13%	-0.44%	1.07%	1.59%	1.41%
Total Shareholder Return	3.70%	2.31%	4.21%	5.62%	6.08%	5.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.